FMC Corp vs Verisign, Inc. — how do they compare? FMC Corp trades at $11.24 (market cap $1.36B), while Verisign, Inc. trades at $274.9 (market cap $24.62B). The key difference: Verisign, Inc. is far larger — about 18.1× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| FMC | VRSN | |
|---|---|---|
Market Cap | $1.36B | $24.62B |
Sector | Basic Materials | Technology |
52-Week High | $43.90 | $310.00 |
52-Week Low | $10.72 | $211.49 |
Enterprise Value | $5.50B | $25.86B |
Dividend Yield | 2.95% | 1.2% |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
VeriSign (VRSN) trades at $268.85, down 0.54% today, with a bullish technical outlook and strong fundamentals. The stock shows consistent revenue growth, reaching $1.66B in 2025, and maintains high profit margins near 50%. Recent Q1 2026 earnings beat expectations at $2.34 EPS, though Q4 2025 missed. Analyst consensus is bullish with a $325.25 price target, and technical indicators suggest support at $265 with resistance at $271.
VRSN offers stable growth driven by its monopoly on .com and .net domains, but faces risks from AI disruption and contract renewals. The stock is fairly valued with a P/E of 29.89, and institutional sentiment is positive. Key risks include high debt levels and competitive threats, yet the company's cash flow and dividend payments support investor confidence.
Trailing returns across standard periods
Latest headlines on both assets
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →